1-3 of 3
Fredrik B Thorén, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Remission after the First Cycle of Induction Chemotherapy Determines the Clinical Efficacy of Relapse-Preventive Immunotherapy in Acute Myeloid Leukemia

Malin S Nilsson, MSc, Alexander Hallner, PhD, Mats Brune, MD PhD, Staffan Nilsson, PhD, Fredrik B Thorén, PhD, Anna Martner, PhD, Kristoffer Hellstrand, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1318.
https://doi.org/10.1182/blood-2019-130345
Published: 2019
Journal Articles

Reactive Oxygen Species Produced By Myeloid Cells Block CD20-Antibody Dependent NK Cell-Mediated Cytotoxicity Against Chronic Lymphocytic Leukemia Cells

Olle Werlenius, MD, Johan Aurelius, PhD, Maria Simpanen, Rebecca E Riise, Ali A Akhiani, PhD, Anna Martner, PhD, Per-Ola Andersson, MD PhD, Kristoffer Hellstrand, MD, Fredrik B Thorén, PhD
Journal: Blood
Blood (2014) 124 (21): 3638.
https://doi.org/10.1182/blood.V124.21.3638.3638
Published: 2014
Journal Articles

Natural Killer Cell Expression of Natural Cytotoxicity Receptors Determines Relapse Risk in Elderly Patients with Acute Myeloid Leukemia Receiving Immunotherapy with Histamine Dihydrochloride and Interleukin-2

Anna Martner, PhD, Anna Rydström, PhD, Rebecca E Riise, Johan Aurelius, PhD, Mats L Brune, MD, Robin Foa, MD, Kristoffer Hellstrand, MD, Fredrik B Thorén, PhD
Journal: Blood
Blood (2014) 124 (21): 3680.
https://doi.org/10.1182/blood.V124.21.3680.3680
Published: 2014